Free Republic
Browse · Search
General/Chat
Topics · Post Article

Skip to comments.

Leukemia drug shows potential against metastatic HER2-positive breast cancer
Medical Xpress / Duke University / Cell Reports ^ | August 31, 2022 | Sarah Avery / Courtney M. McKernan et al

Posted on 08/31/2022 9:08:41 PM PDT by ConservativeMind

In animal studies, a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.

The finding provides evidence for human trials and suggests a potential new approach to derail one of the main ways that breast cancer turns deadly.

"We have made huge strides in treating HER2-positive breast cancers, but when tumors escape the therapies, they often metastasize to the brain," said senior author Ann Marie Pendergast, Ph.D.

"When brain metastasis occurs, treatments are unsuccessful either because the tumors have developed resistance, or the therapies cannot penetrate the blood-brain barrier," Pendergast said. "This remains a devastating diagnosis for patients."

Pendergast and colleagues looked at how HER2 promotes breast cancer growth, particularly after becoming resistant to targeted treatments that have been highly successful in prolonging lives. The HER2 protein is a driving force in 30% of breast cancers, with approximately 45% of these leading to brain metastases.

The researchers focused on a pair of enzymes called ABL1 and ABL2 kinases that regulate the expression of HER2. The researchers found that these kinases play a critical role in creating the conditions that allow HER2 to accumulate on the surface of breast cancer cells, fueling breast cancer tumor metastasis.

Experimenting in mice, Pendergast and her team were able to disrupt the ABL kinases using a leukemia drug called asciminib. A kinase inhibitor, the drug is not impeded by the blood-brain barrier in tumor-bearing mice and interferes with the ABL kinases' signaling mechanism.

By blocking the ABL signaling network, the therapy keeps the HER2 protein from accumulating in the breast cancer cells and shuts down their process for fueling the proliferation and spread of cancer cells.

"These findings support the use of ABL kinase inhibitors for the treatment of HER2-positive brain metastasis," Pendergast said.

(Excerpt) Read more at medicalxpress.com ...


TOPICS: Health/Medicine
KEYWORDS: cancer
A positive development to help against virulent breast cancer.
1 posted on 08/31/2022 9:08:41 PM PDT by ConservativeMind
[ Post Reply | Private Reply | View Replies]

To: Mazey; ckilmer; goodnesswins; Jane Long; BusterDog; jy8z; ProtectOurFreedom; matthew fuller; ...

The “Take Charge Of Your Health” Ping List

This high volume ping list is for health articles and studies which describe something you or your doctor, when informed, may be able to immediately implement for your benefit.

Email me to get on either the “Common/Top Issues” (20% fewer pings) or “Everything” list.

2 posted on 08/31/2022 9:09:25 PM PDT by ConservativeMind (Trump: Befuddling Democrats, Republicans, and the Media for the benefit of the US and all mankind.)
[ Post Reply | Private Reply | To 1 | View Replies]

To: ConservativeMind

Interesting because certain Breast cancer chemo treatments can cause leukemia sometimes.


3 posted on 08/31/2022 10:19:55 PM PDT by HollyB
[ Post Reply | Private Reply | To 1 | View Replies]

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
General/Chat
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson